Cytosorbents Corporation (CTSO) Stock Price

0.35 ▼ -0.0338 (-8.81%)
Open: 0.3568 Vol: 752.75K Day's range: 0.34 - 0.4059 Sep 03, 16:00 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
CTSO Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL SELL SELL SELL SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 0.35▲ 0.35▼ 0.35▼ 0.35▲ 0.36▼
MA10 0.36▼ 0.37▼ 0.37▼ 0.35▼ 0.37▼
MA20 0.37▼ 0.37▼ 0.36▼ 0.36▼ 0.43▼
MA50 0.37▼ 0.36▼ 0.36▼ 0.37▼ 0.61▼
MA100 0.36▼ 0.37▼ 0.38▼ 0.45▼ 0.80▼
MA200 0.39▼ 0.41▼ 0.44▼ 0.57▼ 1.33▼
  5 mins 30 mins Hourly Daily Weekly
MACD -0.003▼ -0.004▼ -0.002▼ 0.001▲ 0.005▲
RSI 40.216▼ 44.746▼ 46.323▼ 47.309▼ 35.399▼
STOCH 9.333▼ 6.717▼ 13.541▼ 39.103     18.496▼
WILL %R -91.741▼ -94.136▼ -90.550▼ -70.879     -83.596▼
CCI -75.307     -98.213     -56.300     33.118     -36.463    
Latest Filters Detected On CTSO
RSI $CTSO RSI(14) Crossed Below 50 Set Alert
MA $CTSO Price Crossed Below MA(50) Set Alert
MA $CTSO Price Crossed Below MA(26) Set Alert
MA $CTSO Price Crossed Below MA(13) Set Alert
▼ GAP $CTSO Open Gap Down %5 Set Alert
▼ GAP $CTSO Open Gap Down %3 Set Alert
▼ GAP $CTSO Open Gap Down %2 Set Alert
Cytosorbents Corporation News
Cytosorbents To Implement 1-For-20 Reverse Stock Split, Stock Down In Pre-Market
Thursday, September 03, 2026 05:25 AM
Thursday, Cytosorbents Corporation ( CTSO) announced its plan to implement a one-for-twenty reverse stock split of its common stock, par value $0.001 per share, effective September 8, 2026.
CTSO: CytoSorbents Announces Very Positive New Real-World Data Demonstrating Significant Reduction in Severe Bleeding Using CytoSorb in CABG Patients on Ticagrelor
Thursday, September 03, 2026 02:30 AM
CTSO READ THE FULL CTSO RESEARCH REPORT New Findings Presented at European Society of Cardiology (ESC) Congress 2026 On September 2, 2026, the CytoSorbents (NASDAQ: CTSO) announced an independent new ...
CytoSorbents Announces New Real-World Data Demonstrating Significant Reduction in Severe Bleeding Using CytoSorb in CABG Patients on Ticagrelor and Updates Recent DrugSorb-ATR ...
Wednesday, September 02, 2026 04:28 AM
CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, today announced an ...
CTSO historical stock data
date open high low close volume
03/09/26 0.3568 0.4059 0.34 0.35 752,753
02/09/26 0.361 0.4717 0.333 0.3838 5,634,385
01/09/26 0.3339 0.35 0.332 0.338 62,740
31/08/26 0.32 0.3441 0.3165 0.341 111,591
28/08/26 0.33 0.3749 0.32 0.3356 113,572
27/08/26 0.3632 0.3749 0.34 0.3404 108,296
26/08/26 0.351 0.3754 0.351 0.36 26,266
25/08/26 0.37 0.39 0.35 0.3553 123,075
24/08/26 0.3441 0.3754 0.3441 0.3754 153,000
21/08/26 0.319 0.3814 0.311 0.37 325,764
Quote Details
52wk Low:0.30
52wk High:1.04
Vol:752.75K
Avg Vol(3m):3.3M
1Y Chng:-63.77%
1M Chng:-2.78%
Add to Watch List
More Information
Index US Composite
Market Cap. 21.99M